|
Volumn 46, Issue 6, 2002, Pages 1896-1905
|
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
AMINO ACID SUBSTITUTION;
ANTIVIRAL ACTIVITY;
ARTICLE;
DNA SEQUENCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LONG TERMINAL REPEAT;
NONHUMAN;
PRIORITY JOURNAL;
THERAPY RESISTANCE;
VIRUS CELL INTERACTION;
VIRUS GENE;
VIRUS MUTATION;
AMINO ACID SEQUENCE;
ANTI-HIV AGENTS;
CLONING, MOLECULAR;
DRUG RESISTANCE, MICROBIAL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GENES, ENV;
GENES, REPORTER;
HIV ENVELOPE PROTEIN GP41;
HIV INFECTIONS;
HIV-1;
HUMANS;
MOLECULAR SEQUENCE DATA;
MUTAGENESIS, SITE-DIRECTED;
PEPTIDE FRAGMENTS;
PHENOTYPE;
RNA, VIRAL;
VIRAL LOAD;
|
EID: 0036090585
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.6.1896-1905.2002 Document Type: Article |
Times cited : (1424)
|
References (28)
|